Plain-English translation of NCT04145219 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Allergic rhinitis research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial studied a medication called HDM SLIT-tablet, which is a dissolvable tablet placed under the tongue to treat house dust mite allergies in children. Researchers tested whether this medication reduced allergy and asthma symptoms better than a placebo (fake tablet) over one year. The study also looked at how safe and well-tolerated the medication was.
House dust mite allergies are common in children and can cause bothersome symptoms like sneezing, congestion, and itchy eyes even when children are already taking allergy medications. This trial was conducted to see if this medication could provide better relief by treating the root cause of the allergy rather than just managing symptoms.
Participants were randomly assigned to receive either the real medication tablet or a placebo tablet to dissolve under their tongue daily for about one year. Throughout the study, children kept track of their allergy and asthma symptoms and medication use, visited the clinic for check-ups, and had their lung function tested. Researchers monitored how well the treatment worked and watched for any side effects.
AI-generated summary from trial data · Aug 22, 2026 · Not medical advice
United States